» Articles » PMID: 15951574

Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2005 Jun 14
PMID 15951574
Citations 921
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We conducted a randomized clinical trial to determine whether treatment of women with gestational diabetes mellitus reduced the risk of perinatal complications.

Methods: We randomly assigned women between 24 and 34 weeks' gestation who had gestational diabetes to receive dietary advice, blood glucose monitoring, and insulin therapy as needed (the intervention group) or routine care. Primary outcomes included serious perinatal complications (defined as death, shoulder dystocia, bone fracture, and nerve palsy), admission to the neonatal nursery, jaundice requiring phototherapy, induction of labor, cesarean birth, and maternal anxiety, depression, and health status.

Results: The rate of serious perinatal complications was significantly lower among the infants of the 490 women in the intervention group than among the infants of the 510 women in the routine-care group (1 percent vs. 4 percent; relative risk adjusted for maternal age, race or ethnic group, and parity, 0.33; 95 percent confidence interval, 0.14 to 0.75; P=0.01). However, more infants of women in the intervention group were admitted to the neonatal nursery (71 percent vs. 61 percent; adjusted relative risk, 1.13; 95 percent confidence interval, 1.03 to 1.23; P=0.01). Women in the intervention group had a higher rate of induction of labor than the women in the routine-care group (39 percent vs. 29 percent; adjusted relative risk, 1.36; 95 percent confidence interval, 1.15 to 1.62; P<0.001), although the rates of cesarean delivery were similar (31 percent and 32 percent, respectively; adjusted relative risk, 0.97; 95 percent confidence interval, 0.81 to 1.16; P=0.73). At three months post partum, data on the women's mood and quality of life, available for 573 women, revealed lower rates of depression and higher scores, consistent with improved health status, in the intervention group.

Conclusions: Treatment of gestational diabetes reduces serious perinatal morbidity and may also improve the woman's health-related quality of life.

Citing Articles

Improving maternal and PeRinatal Outcomes aMong wOmen with and without obEsity (PROMOTE): protocol for a prospective pregnancy cohort study.

Samarawickrama Lucewicz A, Rhou Y, Melov S, Elhindi J, Patel S, Flood V BMJ Open. 2025; 15(3):e090930.

PMID: 40054873 PMC: 11891537. DOI: 10.1136/bmjopen-2024-090930.


Detection of Novel hub-methylated differentially expressed genes in pregnant women with gestational diabetes mellitus via WGCNA of epigenome-wide and transcriptome-wide profiling.

Hamdan H Int J Health Sci (Qassim). 2025; 19(2):4-16.

PMID: 40046791 PMC: 11877056.


Gestational hyperglycaemia impacts glucose control and insulin sensitivity in mouse offspring.

Hribar K, Fisher J, Eichhorn D, Smit M, Kloosterhuis N, Bakker B Sci Rep. 2025; 15(1):7136.

PMID: 40021748 PMC: 11871037. DOI: 10.1038/s41598-025-91662-0.


The TANGO-DM randomized controlled trial study protocol: treatment outcomes for gestational diabetes diagnosed according to WHO 2013 or WHO 1999 thresholds.

Rademaker D, de Wit L, van der Wel A, van den Akker E, Braams-Lisman B, Dullemond R BMC Pregnancy Childbirth. 2025; 25(1):173.

PMID: 39962444 PMC: 11834261. DOI: 10.1186/s12884-025-07230-x.


Maternal and Neonatal Efficacy and Safety Outcomes of Myo-Inositol in Women With or at High Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Ali Y, Sharara M, Mahrous M, Rezk A, Abuali A, Seoudy M Diabetes Spectr. 2025; 38(1):82-92.

PMID: 39959527 PMC: 11825409. DOI: 10.2337/ds23-0065.